Revenue, Revenue by Region Based on Location of Customer (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) Customer	Dec. 31, 2022 USD ($) Customer	Dec. 31, 2021 USD ($) Customer
Revenue Recognition [Abstract]
Total revenue from sale of therapies	$ 238,735	$ 140,687	$ 4,078
Medison [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage		10.00%	10.00%
Medison [Member] | Customers [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Number of customers | Customer	4	5	1
Medison [Member] | Customer 1 [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage	29.00%	26.00%
Medison [Member] | Customer 2 [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage	26.00%	25.00%
Medison [Member] | Customer 3 [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage	17.00%	17.00%
Medison [Member] | Customer 4 [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage	16.00%	17.00%
Medison [Member] | Customer 5 [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Revenue Recognition [Abstract]
Concentration Risk, Percentage		12.00%
United States [Member]
Revenue Recognition [Abstract]
Total revenue from sale of therapies	$ 169,791	$ 96,893	$ 0
Europe [Member]
Revenue Recognition [Abstract]
Total revenue from sale of therapies	67,628	42,745	4,078
International [Member]
Revenue Recognition [Abstract]
Total revenue from sale of therapies	1,316	1,049	0
International [Member] | Medison [Member]
Revenue Recognition [Abstract]
Total revenue from sale of therapies	$ 3,600	$ 1,900	$ 0